Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Chiodo

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
ACS Central Science|September 5, 2019
Synthetic, Zwitterionic Sp1 Oligosaccharides Adopt a Helical Structure Crucial for Antibody InteractionQingju Zhang, Ana Gimeno, Darielys Santana, et al.
Angewandte Chemie (International Ed. in English)|September 30, 2025
Decoding a Gut Commensal Signal: Structural and Immunological Profiling of Segatella Copri LipopolysaccharideLuca De Simone Carone, Giusi Barra, Roberta Cirella, et al.
The FEBS Journal|March 22, 2021
Emerging glyco-based strategies to steer immune responsesMarko Anderluh, Francesco Berti, Anna Bzducha-Wróbel, et al.
The FEBS Journal|May 2, 2021
Recent advances on smart glycoconjugate vaccines in infections and cancerMarko Anderluh, Francesco Berti, Anna Bzducha-Wróbel, et al.
Plos Neglected Tropical Diseases|June 26, 2023
Schistosoma mansoni egg-derived thioredoxin and Sm14 drive the development of IL-10 producing regulatory B cellsMathilde A M Chayé, Thomas A Gasan, Arifa Ozir-Fazalalikhan, et al.
The Lancet. Respiratory Medicine|June 12, 2022
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trialRolando Ochoa-Azze, Arturo Chang-Monteagudo, Yanet Climent-Ruiz, et al.
ACS Chemical Biology|July 5, 2021
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical StudiesYury Valdes-Balbin, Darielys Santana-Mederos, Lauren Quintero, et al.
RSC Chemical Biology|April 1, 2022
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and <i>Neisseria meningitidis</i> outer membrane vesiclesDarielys Santana-Mederos, Rocmira Perez-Nicado, Yanet Climent, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
ACS Central Science|September 5, 2019
Synthetic, Zwitterionic Sp1 Oligosaccharides Adopt a Helical Structure Crucial for Antibody InteractionQingju Zhang, Ana Gimeno, Darielys Santana, et al.
Angewandte Chemie (International Ed. in English)|September 30, 2025
Decoding a Gut Commensal Signal: Structural and Immunological Profiling of Segatella Copri LipopolysaccharideLuca De Simone Carone, Giusi Barra, Roberta Cirella, et al.
The FEBS Journal|March 22, 2021
Emerging glyco-based strategies to steer immune responsesMarko Anderluh, Francesco Berti, Anna Bzducha-Wróbel, et al.
The FEBS Journal|May 2, 2021
Recent advances on smart glycoconjugate vaccines in infections and cancerMarko Anderluh, Francesco Berti, Anna Bzducha-Wróbel, et al.
Plos Neglected Tropical Diseases|June 26, 2023
Schistosoma mansoni egg-derived thioredoxin and Sm14 drive the development of IL-10 producing regulatory B cellsMathilde A M Chayé, Thomas A Gasan, Arifa Ozir-Fazalalikhan, et al.
The Lancet. Respiratory Medicine|June 12, 2022
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trialRolando Ochoa-Azze, Arturo Chang-Monteagudo, Yanet Climent-Ruiz, et al.
ACS Chemical Biology|July 5, 2021
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical StudiesYury Valdes-Balbin, Darielys Santana-Mederos, Lauren Quintero, et al.
RSC Chemical Biology|April 1, 2022
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and <i>Neisseria meningitidis</i> outer membrane vesiclesDarielys Santana-Mederos, Rocmira Perez-Nicado, Yanet Climent, et al.
Pageof 6